CERO THERAPEUTICS HOLDINGS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-04-15
- CERO THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $348.12K, a 16.06% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $183.33K, a 86.80% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-09-30 was $414.74K.
- CERO THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-06-30 was $1.39M.
- CERO THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $1.10M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2025-12-31 | $1.10M 10-K · filed 2026-04-15 | ||
| 2025-09-30 | $348.12K 10-Q · filed 2025-11-19 | $531.44K derived: sum of 2 quarters · filed 2025-11-19 | |
| 2025-06-30 | $183.33K 10-Q · filed 2025-11-19 | ||
| 2024-09-30 | $414.74K 10-Q · filed 2025-11-19 | $1.80M derived: sum of 2 quarters · filed 2025-11-19 | |
| 2024-06-30 | $1.39M 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |